Oscar A Garcia Valencia, Charat Thongprayoon, Jing Miao, Supawadee Suppadungsuk, Pajaree Krisanapan, Iasmina M Craici, Caroline C Jadlowiec, Shennen A Mao, Michael A Mao, Napat Leeaphorn, Pooja Budhiraja, Wisit Cheungpasitporn
Empowering inclusivity: improving readability of living kidney donation information with ChatGPT
Frontiers in digital health
although statins reduce adverse cardiovascular outcomes less onehalf eligible patients receive treatment nonprescription statin potential improve access statins study sought assess concordance clinician consumer assessment eligibility nonprescription statin treatment using technology assisted selfselection web application web app evaluate effect lowdensity lipoprotein cholesterol ldlc levels study prospective actual use 6month study evaluate use web app qualify participants without medical background moderateintensity statin based current guidelines participants entered demographic information cholesterol values blood pressure concomitant medications web app resulting 3 possible outcomes use ask doctor ok use study included 1196 participants median age 63 years q1q3 5768 years 396 women 793 white 117 black 41 limited literacy mean ldlc 1396 283 mgdl median calculated 10year risk atherosclerotic cardiovascular disease 101 q1q3 73140 initial web app selfselection resulted outcome concordant clinician assessment 907 95 ci 889923 participants 981 95 ci 971988 concordant final use outcome treatment mean percent change ldlc 355 95 ci 366 343 serious adverse events occurred 27 23 participants none related study drug actual use study technologyassisted web app allowed 90 consumers correctly selfselect statin use achieve clinically important ldlc reductions technologyassisted cholesterol trial consumers tactic nct04964544